Department of Biology, College of Art and Science, University of Kentucky, Lexington, KY, USA.
Neuroscience. 2012 Dec 6;225:65-75. doi: 10.1016/j.neuroscience.2012.08.058. Epub 2012 Sep 6.
Traumatic brain injury (TBI) survivors experience long-term post-traumatic morbidities. In diffuse brain-injured rats, a chronic sensory sensitivity to whisker stimulation models the agitation of TBI survivors and provides anatomical landmarks across the whisker-barrel circuit to evaluate post-traumatic neuropathology. As a consequence of TBI, acute and chronic microglial activation can contribute to degenerative and reparative events underlying post-traumatic morbidity. Here we hypothesize that a temporal sequence of microglial activation states contributes to the circuit pathology responsible for post-traumatic morbidity, and test the hypothesis by examining microglial morphological activation and neuroinflammatory markers for activation states through gene expression and receptor-binding affinity. Adult male, Sprague-Dawley rats were subjected to a single moderate midline fluid percussion injury (FPI) or sham injury. Microglial activation was determined by immunohistochemistry, quantitative real-time PCR and receptor autoradiography in the primary somatosensory barrel field (S1BF) and ventral posterior medial nucleus (VPM) of the thalamus at 7 and 28 days following FPI. Morphological changes indicative of microglial activation, including swollen cell body with thicker, shrunken processes, were evident in S1BF and VPM at 7 and 28 days post-injury. Principally at 7 days post-injury in VPM, general inflammatory gene expression (major histocompatibility complex I, major histocompatibility complex II, translocator protein 18 kDa [TSPO]) is increased above sham level and TSPO gene expression confirmed by receptor autoradiography. Further, CD45, a marker of classical activation, and TGF-βI, an acquired deactivation marker, were elevated significantly above sham at 7 days post-injury. Daily administration of the anti-inflammatory ibuprofen (20mg/kg, i.p.) significantly reduced the expression of these genes. Evidence for alternative activation (arginase 1) was not observed. Thus, these data demonstrate concomitant classical activation and acquired deactivation phenotypes of microglia in diffuse TBI in the absence of overt contusion or cavitation. Anti-inflammatory treatment may further alleviate the neuropathological burden of post-traumatic inflammation.
创伤性脑损伤 (TBI) 幸存者会经历长期的创伤后病态。在弥漫性脑损伤大鼠中,慢性对胡须刺激的感觉敏感性模拟了 TBI 幸存者的激动状态,并为评估创伤后神经病理学提供了横跨胡须-桶状皮层回路的解剖学标志物。由于 TBI,急性和慢性小胶质细胞激活可能导致创伤后病态的退行性和修复性事件。在这里,我们假设小胶质细胞激活状态的时间序列有助于导致创伤后病态的回路病理学,并通过基因表达和受体结合亲和力检查小胶质细胞形态激活和神经炎症标志物来检验这一假设。成年雄性 Sprague-Dawley 大鼠接受单次中线液流冲击损伤 (FPI) 或假手术。在 FPI 后 7 天和 28 天,通过免疫组织化学、实时定量 PCR 和受体放射自显影术,在初级体感皮层 (S1BF) 和丘脑腹后内侧核 (VPM) 中确定小胶质细胞的激活。在 S1BF 和 VPM 中,在受伤后 7 天和 28 天可见到表明小胶质细胞激活的形态变化,包括肿胀的细胞体和更厚、萎缩的突起。主要在 VPM 中,在损伤后 7 天,一般炎症基因表达 (主要组织相容性复合体 I、主要组织相容性复合体 II、转位蛋白 18kDa[TSPO]) 高于假手术水平,TSPO 基因表达通过受体放射自显影术得到证实。此外,CD45,经典激活标志物,和 TGF-βI,获得性失活标志物,在受伤后 7 天明显高于假手术组。每天给予抗炎药布洛芬 (20mg/kg,腹腔注射) 可显著降低这些基因的表达。未观察到替代激活 (精氨酸酶 1) 的证据。因此,这些数据表明在弥漫性 TBI 中,在没有明显挫伤或空洞的情况下,小胶质细胞存在同时的经典激活和获得性失活表型。抗炎治疗可能进一步减轻创伤后炎症的神经病理学负担。